Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Clonal Hematopoiesis Drives Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation and Propagates during Disease Evolution

Johannes Frasez Sørensen, Anni Aggerholm, Marcus H Hansen, MSc, Gitte Birk Kerndrup, MD DMSc, Lene Hyldahl Ebbesen, MD PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD PhD, Maja Ludvigsen, MSc, PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-141993

Published: 2020

Journal Articles

A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity

Blood (2019) 134 (Supplement_1): 4141.

https://doi.org/10.1182/blood-2019-131113

Published: 2019

Journal Articles

Exploring Imaging Flow Cytometry As a Tool for Evaluating Dyserythropoiesis in Myelodysplastic Syndrome

Carina A Rosenberg, MSc, PhD, Marie Bill, MD PhD, Gitte Birk Kerndrup, MD DMSc, Mathias Hauerslev, Peter Hokland, MD DMSc, Maja Ludvigsen, MSc, PhD

Blood (2018) 132 (Supplement 1): 5508.

https://doi.org/10.1182/blood-2018-99-111555

Published: 2018

Journal Articles

Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation: The Prevalence of Chip Mutations at Time of Transplantation — a Single Center Experience

Johannes Frasez Soerensen, Anni Aggerholm, MSc, PhD, Gitte Birk Kerndrup, MD DMSc, Marcus C Hansen, MSc, Ina Kathrine Lykke Ewald, Lene Hyldahl Ebbesen, MD PhD, Carina A Rosenberg, MSc, PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD Ass. Prof, Maja Ludvigsen, MSc, PhD

Blood (2018) 132 (Supplement 1): 1529.

https://doi.org/10.1182/blood-2018-99-114482

Published: 2018

Journal Articles

A New Approach to Identify Pathogenic Mutations and Inherited Variants By Exome Sequencing – Using a Pair of Identical Twins with Monoclonal Lymphosis As Case Model

Marcus Celik Hansen, MSc in Biomedical Engineering, Charlotte Guldborg Nyvold, MSc, PhD, Anne Stidsholt Roug, MD PhD, Line Nederby, MSc, PhD, Peter Hokland, MD DMSc

Blood (2014) 124 (21): 1979.

https://doi.org/10.1182/blood.V124.21.1979.1979

Published: 2014

Journal Articles

MiR-300 Acts As a Tumor Supressor in Ph+ Progenitors By Modulating the JAK2-SET/PP2A/β-Catenin Interplay

Giovannino Silvestri, PhD, Justin Ellis, Lorenzo Stramucci, PhD, Jason G Harb, PhD, Paolo Neviani, PhD, Guido Marcucci, MD, Denis-Claude Roy, MD, Peter Hokland, MD DMSc, Dragana Milojkovic, Alistair Reid, Jane F. Apperley, Ferenc M Livak, PhD, Maria R. Baer, MD, Rossana Trotta, PhD, Danilo Perrotti, MD PhD

Blood (2014) 124 (21): 4529.

https://doi.org/10.1182/blood.V124.21.4529.4529

Published: 2014

Journal Articles

SOX11, CCND1, BCL1/Igh, and Igh-VDJ – a Plethora of Markers for Minimal Residual Disease in Mantle Cell Lymphoma: Which One to Choose?

Anita Tranberg Simonsen, MSc., Marie Schou, Camilla Darum Sørensen, MSc., Peter Hokland, MD DMSc, Hans Bentzen, MD PhD, Charlotte Guldborg Nyvold, MSc, PhD

Blood (2014) 124 (21): 2957.

https://doi.org/10.1182/blood.V124.21.2957.2957

Published: 2014

Journal Articles

High Fractions of CD34+CD38- Cells with Aberrant hMICL Expression Predicts Shorter Overall- and Progression Free Survival in Myelodysplastic Syndrome

Marie Toft-Petersen, MD, Line Nederby, MSc, PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD PhD

Blood (2014) 124 (21): 3235.

https://doi.org/10.1182/blood.V124.21.3235.3235

Published: 2014

Journal Articles

Relapse Kinetics in Acute Myeloid Leukemis Cases Encompassing More Than One Common Mutation: Towards a Unified Model

Hans Beier Ommen, MD PhD, Maria Hansen, MSc, PhD, Charlotte Guldborg Nyvold, MSc, PhD, Peter Hokland, MD DMSc

Blood (2014) 124 (21): 1055.

https://doi.org/10.1182/blood.V124.21.1055.1055

Published: 2014

Journal Articles

Characterisation of the Stem and Progenitor Cell Hierarchy in Patients with CMML

Onima Chowdhury, MD PhD, Petter S Woll, PhD, Una Kjällquist, PhD, Helen Doolittle, MD, Rikard Erlandsson, PhD, Kristina Anderson, MD PhD, Ingunn Dybedal, MD PhD, Adam Mead, MDPhD, Sally-Ann Clark, PhD, Mette S. Holm, MD PhD, Peter Hokland, MD DMSc, Lars Nilsson, MD PhD, Sten Linnarsson, PhD, Eva Hellstrom-Lindberg, MD PhD, Sten Eirik W Jacobsen, MD PhD

Blood (2014) 124 (21): 1896.

https://doi.org/10.1182/blood.V124.21.1896.1896

Published: 2014

Journal Articles

Cell Sorting Enables iFISH Detection Of Low BCR-ABL Producing Stem Cells In CML Patients Beyond Deep Molecular Remission

Peter Buur van Kooten Niekerk, MD, Charlotte Christie Petersen, MSc PhD, Charlotte Guldborg Nyvold, MSc, PhD, Hans Beier Ommen, MD, PhD, Anne Stidsholt Roug, MD, PhD, Line Nederby, MSc, PhD, Peter Hokland, MD, DMSC, Eigil Kjeldsen

Blood (2013) 122 (21): 1501.

https://doi.org/10.1182/blood.V122.21.1501.1501

Published: 2013

Journal Articles

Human MICL Is An Early Marker In Myeloid Differentiation and Identifies a Subgroup Of CML Patients With Expanded Granulocyte-Macrophage Progenitor Populations At Diagnosis

Peter Buur van Kooten Niekerk, MD, Anne Stidsholt Roug, MD, PhD, Charlotte Christie Petersen, MSc PhD, Line Nederby, MSc, PhD, Charlotte Guldborg Nyvold, MSc, PhD, Ole Weis Bjerrum, MD, Andreja Dimitrijevic, MD, Marianne T. Severinsen, MD, PhD, Jesper Stentoft, MD, PhD, Peter Hokland, MD, DMSC

Blood (2013) 122 (21): 2704.

https://doi.org/10.1182/blood.V122.21.2704.2704

Published: 2013

Journal Articles

Diverse Genetic Lesions In Myelodysplastic Syndromes Originate Exclusively In Rare MDS Stem Cells

Blood (2013) 122 (21): 4195.

https://doi.org/10.1182/blood.V122.21.4195.4195

Published: 2013

Journal Articles

Unraveling The Leukemic Nature Of hMICL and CD123 Expressing Cells In Acute Myeloid Leukemia

Line Nederby, MSc, PhD, Peter Hokland, MD, DMSC, Gordon Brown, MSc, PhD, Maria Hansen, MSc, PhD, Charlotte Guldborg Nyvold, MSc, PhD, Anne Stidsholt Roug, MD, PhD

Blood (2013) 122 (21): 2626.

https://doi.org/10.1182/blood.V122.21.2626.2626

Published: 2013

Journal Articles

Evaluation of hMICL As a Marker Associated with Disease Progression in BCR-ABL Negative Myeloproliferative Neoplasms

Line Nederby, MSc, PhD, Laura Laine Larsen, Peter Hokland, MD, DMSC, Anne Stidsholt Roug, MD, PhD

Blood (2012) 120 (21): 1724.

https://doi.org/10.1182/blood.V120.21.1724.1724

Published: 2012

Journal Articles

Poor Mobilizers in an Autologous Hematopoietic Stem Cell Transplantation Setting: Matched Pair Analysis Profiling G-CSF and Plerixafor-Mobilized Stem Cells

Line Nederby, MSc, PhD, Lea Bjerre Hokland, MSc, PhD, Katrine Nielsen, MD, Erik Kay Segel, MD, Peter Hokland, MD, DMSC, Anne Stidsholt Roug, MD, PhD

Blood (2012) 120 (21): 4413.

https://doi.org/10.1182/blood.V120.21.4413.4413

Published: 2012

Journal Articles

Chronic Myeloid Leukemia Presenting with Isolated Thrombocythemia: A Case Revealing Its Stem Cell Biology

Peter Buur van Kooten Niekerk, MD, Anne Stidsholt Roug, MD, PhD, Line Nederby, MSc, PhD, Charlotte Christie Petersen, MSc, Hans Beier Ommen, MD, PhD, Eigil Kjeldsen, MD, Knud Bendix, Charlotte Guldborg Nyvold, MSc, PhD, Peter Hokland, MD, DMSC

Blood (2012) 120 (21): 4427.

https://doi.org/10.1182/blood.V120.21.4427.4427

Published: 2012

Journal Articles

Sensitivity of MRD Detection in AML: qPCR Vs. MFC - a Plethora to Choose From, but Which Is Best?

Anne Stidsholt Roug, MD, Hanne Oestergaard Larsen, PhD, MSc,, Hans Beier Ommen, MD, PhD, Peter Hokland, MD, DMSC

Blood (2011) 118 (21): 1447.

https://doi.org/10.1182/blood.V118.21.1447.1447

Published: 2011

Journal Articles

Mathematical Modeling and Comparisons of Relapse Patterns in AML with 11q23/ MLL translocations and Normal Karyotype AML with MLL -PTD

Hans Beier Ommen, MD, PhD, Peter Hokland, MD, DMSC, Torsten Haferlach, MD, Tamara Alpermann, Claudia Haferlach, MD, Wolfgang Kern, MD, Susanne Schnittger, PhD

Blood (2011) 118 (21): 750.

https://doi.org/10.1182/blood.V118.21.750.750

Published: 2011

Journal Articles

A New Protocol for Efficient and Non-Toxic Transfection of siRNA Into Leukemic Cell Lines and Primary Cells – a Direct Comparison Between Nucleofection and Accell Delivery Using Stem Cell Related Antigens As Validation Tools

Hanne Østergaard Larsen, MSci, PhD, Anne Stidsholt Roug, MD, Claus Svane Sondergaard, MSci, PhD, Peter Hokland, MD, DMSC

Blood (2011) 118 (21): 4802.

https://doi.org/10.1182/blood.V118.21.4802.4802

Published: 2011

NARROW

Clonal Hematopoiesis Drives Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation and Propagates during Disease Evolution

A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity

Exploring Imaging Flow Cytometry As a Tool for Evaluating Dyserythropoiesis in Myelodysplastic Syndrome

Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation: The Prevalence of Chip Mutations at Time of Transplantation — a Single Center Experience

A New Approach to Identify Pathogenic Mutations and Inherited Variants By Exome Sequencing – Using a Pair of Identical Twins with Monoclonal Lymphosis As Case Model

MiR-300 Acts As a Tumor Supressor in Ph+ Progenitors By Modulating the JAK2-SET/PP2A/β-Catenin Interplay

SOX11, CCND1, BCL1/Igh, and Igh-VDJ – a Plethora of Markers for Minimal Residual Disease in Mantle Cell Lymphoma: Which One to Choose?

High Fractions of CD34+CD38- Cells with Aberrant hMICL Expression Predicts Shorter Overall- and Progression Free Survival in Myelodysplastic Syndrome

Relapse Kinetics in Acute Myeloid Leukemis Cases Encompassing More Than One Common Mutation: Towards a Unified Model

Characterisation of the Stem and Progenitor Cell Hierarchy in Patients with CMML

Cell Sorting Enables iFISH Detection Of Low BCR-ABL Producing Stem Cells In CML Patients Beyond Deep Molecular Remission

Human MICL Is An Early Marker In Myeloid Differentiation and Identifies a Subgroup Of CML Patients With Expanded Granulocyte-Macrophage Progenitor Populations At Diagnosis

Diverse Genetic Lesions In Myelodysplastic Syndromes Originate Exclusively In Rare MDS Stem Cells

Unraveling The Leukemic Nature Of hMICL and CD123 Expressing Cells In Acute Myeloid Leukemia

Evaluation of hMICL As a Marker Associated with Disease Progression in BCR-ABL Negative Myeloproliferative Neoplasms

Poor Mobilizers in an Autologous Hematopoietic Stem Cell Transplantation Setting: Matched Pair Analysis Profiling G-CSF and Plerixafor-Mobilized Stem Cells

Chronic Myeloid Leukemia Presenting with Isolated Thrombocythemia: A Case Revealing Its Stem Cell Biology

Sensitivity of MRD Detection in AML: qPCR Vs. MFC - a Plethora to Choose From, but Which Is Best?

Mathematical Modeling and Comparisons of Relapse Patterns in AML with 11q23/ MLL translocations and Normal Karyotype AML with MLL -PTD

A New Protocol for Efficient and Non-Toxic Transfection of siRNA Into Leukemic Cell Lines and Primary Cells – a Direct Comparison Between Nucleofection and Accell Delivery Using Stem Cell Related Antigens As Validation Tools

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only